October 24, 2007 – During a live demonstration at TCT 2007 of CoreValve’s 18-French ReValving System for percutaneous aortic valve replacement (PAVR), cardiologists performed the implantation of the device in a high-risk patient suffering from Chronic Obstructive Pulmonary Disease (COPD).

October 24, 2007 - Presented at the TCT 2007 meeting, a pooled analysis of safety data from Medtronic’s ENDEAVOR clinical program affirmed the superior safety of the Endeavor drug-eluting coronary stent compared to Medtronic’s bare metal stent, Driver, indicating comparable safety to a bare-metal stent.

October 24, 2007 - Spectranetics Corp. announced at TCT 2007 that its CELLO (CLiRpath Excimer Laser System to Enlarge Lumen Openings) clinical trial exceeded the targeted primary endpoint by achieving significant tissue removal and demonstrating the ability of laser ablation facilitated by the TURBO-Booster to restore blood flow in the superficial femoral artery.

October 25, 2007 - Cordis Corp. announced at TCT 2007 the U.S. and European launch of Cordis’s next generation carotid stent system, the PRECISE PRO RX Nitinol Self-Expanding Stent, designed to treat clogged neck arteries and enable more efficient manipulation of the catheter and guidewire during stenting procedures and better crossability.

October 25, 2007 – Ceremed's Ostene, designed to stop bone bleeding in surgery, reportedly does not interfere with bone healing or increase the risk of surgical infections, including MRSA.

This FDA approved and CE marked novel biomaterial is used in cardiac, orthopedic, and neurosurgery and has additional applications as a safe, soluble delivery vehicle for a variety of therapeutic agents, from antibiotics to bone growth factors, according to the manufacturer.

October 24, 2007 – St. Jude Medical took the stage at TCT 2007 to introduce its new hybrid carotid guiding sheath, Strada, which is built like a guide wire by blending sheath and catheter guide wire technology in order to reach tortuous vascular vessels.

Cordis Corp. introduced next generation carotid stent system, the PRECISE PRO RX Nitinol Self-Expanding Stent, designed to treat clogged neck arteries and enable more efficient manipulation of the catheter and guidewire during stenting procedures and better crossability.

October 24, 2007 – ev3 Inc. highlighted at TCT 2007 its merger with FoxHollow Technologies, Inc., which created an organization that possesses one of the largest U.S. distribution footprints in endovascular devices with combined technologies for the advancement of the treatment of peripheral and neurovascular disease.

October 23, 2007 - PLC Systems Inc. introduced at TCT 2007 the RenalGuard System, an investigational system and therapy that targets patients with compromised renal function who may be at risk for contrast-induced nephropathy, or CIN, when undergoing cardiovascular imaging procedures.

October 23, 2007 – After 12 months of the SPIRIT III trial, there were significantly fewer major adverse cardiac events (MACE) such as heart attacks, deaths from cardiac causes or repeat procedures (angioplasty or surgery) to clear the original vessel blockage after using a Xience V everolimus-eluting coronary stent than a Taxus paclitaxel-eluting stent, researchers reported at TCT 2007.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now